Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

ESMO Colloquium supported by Astellas - State of the art management of mCPRC

Optimal first-line treatment in mCRPC after either chemo or ARI in mHSPC

Date

24 Nov 2019

Session

ESMO Colloquium supported by Astellas - State of the art management of mCPRC

Topics

Tumour Site

Prostate Cancer

Presenters

Cora Sternberg

Authors

C.N. Sternberg

Author affiliations

  • Medical Oncology Department, Weill Cornell Medicine - The Blenis Lab, 10021 - New York/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Immunotherapy in mCRPC management

Presenter: Arun Azad

Session: ESMO Colloquium supported by Astellas - State of the art management of mCPRC

Resources:

Slides

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.